As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis.
With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD.
The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.
In Collaboration with
Exploring the DINE-CD Study & the Importance of Diet for IBD Patients
Exploring the DINE-CD Study & the Importance of Diet for IBD Patients
Endoscopic & Histological Assessment, Correlation, & Relapse in Clinically Quiescent Ulcerative Colitis
Endoscopic & Histological Assessment, Correlation, & Relapse in Clinically Quiescent Ulcerative Colitis
Keeping CALM in Crohn’s Disease: An Exploration of Biomarker Cutoffs & Endoscopic Outcomes
Keeping CALM in Crohn’s Disease: An Exploration of Biomarker Cutoffs & Endoscopic Outcomes
Crohn’s & Colitis Congress 2021: Getting a Holistic View of IBD Diet Disparities & Well-Being
Crohn’s & Colitis Congress 2021: Getting a Holistic View of IBD Diet Disparities & Well-Being
Crohn’s & Colitis Congress 2021: Challenges & Approaches to Managing IBD in the COVID-19 Era
Crohn’s & Colitis Congress 2021: Challenges & Approaches to Managing IBD in the COVID-19 Era
Crohn’s & Colitis Congress 2021: The Future of IBD Treatments
Crohn’s & Colitis Congress 2021: The Future of IBD Treatments
Crohn’s & Colitis Congress 2021: Incorporating IBD Therapies
Crohn’s & Colitis Congress 2021: Incorporating IBD Therapies
Crohn’s & Colitis Congress 2021: Caring for Children with IBD Amid the Pandemic
Crohn’s & Colitis Congress 2021: Caring for Children with IBD Amid the Pandemic
Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD
Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD
Crohn’s & Colitis Congress 2021: Making the Most of IBD Treatment
Crohn’s & Colitis Congress 2021: Making the Most of IBD Treatment
FMT & the Growing Treatment Landscape for IBD
FMT & the Growing Treatment Landscape for IBD
Counteracting Chronic Pain in Patients with IBD
Counteracting Chronic Pain in Patients with IBD
Exploring the Role of Cannabis in Inflammatory Bowel Disease
Exploring the Role of Cannabis in Inflammatory Bowel Disease
Understanding the Importance of Nutrition in IBD
Understanding the Importance of Nutrition in IBD
A Perspective on Pediatric Inflammatory Bowel Disease
A Perspective on Pediatric Inflammatory Bowel Disease
